medigraphic.com
Asociación Mexicana de Gastroenterología

2007, Number 3

Next >>

Rev Gastroenterol Mex 2007; 72 (3)

Evaluation of lipid digestion using the 13C-mixed triglyceride breath test in patients with chronic pancreatitis

Morán-Villota S, Arteaga ME, Rodríguez-Leal GA, Medina-Zavala M, Gallardo-Wong I, Milke-García P, Dehesa-Violante M

Language: Spanish
References: 23
Page: 202-206
PDF size: 60.43 Kb.


ABSTRACT

Background: Steatorrhea represents the indirect sign of lipid maldigestion in chronic pancreatitis and even when the measurement of fecal fat is considered as a gold standard for the diagnosis of steatorrhea, this test is not commonly used within clinical practice because of the inconvenience related to sample collection. Although the use of breath test using mixted tryglicerides was initally validated as an indirect alternative for the assessment of exocrine pancreas reserve, only recently has used this method as a surrogate for the measurement of fat in feces. Aim: To evaluate fat digestion by means of the breath test with 13C labelled mixed triglycerides in patients with chronic pancreatitis. Material and methods: Patients with chronic pancreatitis underwent clinical and biochemical evaluation. The latter included serum amylase, lipase, betacarotenes; fecal fat analysis and breath test using 13C-mixed tryglicerides. Breath test results are expressed as the percentage of 13C recovered in the breath sample. Results: Seventeen patients (age: 45 ± 5 years) were included, of which 7 had steatorrhea (fecal fat greater than 7 g/day). In patients with steatorrhea, the percentage of recovered 13C from breath was significantly lower (6 ± 4%) than in patients without it (25 ± 5%). Conclusion: Results suggest the uselfuness of breath test with 13C-mixed tryglicerides as an alternative for the assessment of lipid digestion in patients with chronic pancreatitis.


REFERENCES

  1. Swart GR, van den Berg JW. 13C breath test in gastroenterological practice. Scand J Gastroenterol Suppl 1998; 225: 13-8.

  2. Einarsson K, Bjorkheim I, Eklof R, Blonestrand R. 14C-triolein breath test as a rapid and a convenient screening test for fat malabsortion. Scan J Gastroenterol 1983; 18: 9-12.

  3. Turner JM, Lawrence S, Fellows IW, Johnson I, Hill PG, Holmes GK. [14C]-triolein absorption: a useful test in the diagnosis of malabsorption. Gut 1987; 28: 694-700.

  4. Cole SG, Rossi S, Stern A, Hofmann AF. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Gastroenterol 1987; 93: 1372-80.

  5. Ventrucci M, Cipolla A, Ubalducci GM, Roda A, Roda E. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 1998; 42: 81-7.

  6. Mundlos S, Rhodes JB, Hofmann AF. The cholesteryl octanoate breath test: a new procedure for detection of pancreatic insufficiency in the rat. Pediatr Res 1987; 22: 257-61.

  7. Vantrappen GR, Rutgeerts PJ, Ghoos YF, Hiele MI. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 1989; 96: 1126-34.

  8. Loser C, Brauer C, Aygen S, Hennemann O, Folsch UR. Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol 1998; 33: 1118-20.

  9. Bai JC, Andrush A, Matelo G, Martinez C, Vazquez H, Boerr L, et al. Fecal fat concentration in the differential diagnosis of steatorrhea. Am J Gastroenterol 1989; 84: 27-30.

  10. Bo-Linn GW, Fordtran JS. Fecal fat concentration in patients with steatorrhea. Gastroenterology 1984; 87: 319-22.

  11. Dominguez-Muñoz JE, Iglesias-Garcia J, Vilariño-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to asses oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2007, 5: 484-8.

  12. Etemad B, Whitocomb D. Chronic pancreatitis: diagnosis, classification and new genetics developments. Gastroenterology 2001; 120: 682-707.

  13. Robles-Diaz, Vargas F, Uscanga L, Fernández-del Castillo C. Chronic pancreatitis in Mexico City. Pancreas 1990; 5: 479-83.

  14. Schlosser W, Rau BM, Poch B, Beger HG. Surgical treatment of pancreas divisum causing chronic pancreatitis: the outcome benefits of duodenum-preserving pancreatic head resection. J Gastrointest Surg 2005; 9: 710-15.

  15. Yan MX, Li YQ. Gallstones and chronic pancreatitis: the black box in between. Posgrad Med J 2006; 82: 254-8.

  16. Van de Kamer JH, Huinink HB. Rapid method for the determination of fat in feces. J Biol Chem 1949; 177: 347-55.

  17. Amarri S, Weaver LT. 13C breath test to measure fat and carbohydrate digestion in clinical practice. Clin Nutr 1995; 14: 149-54.

  18. Weaver LT, Amarri S, Swart GR. 13C mixed triglyceride breath test. Gut 1998; 43(Suppl 3): S13-19.

  19. DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme ouputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 1973; 19; 288: 813-15.

  20. Slater C, Ling SC, Preston T, Weaver LT. Analysis of 13C-mixed triacylglycerol in stool by bulk (EA-IRMS) and compound specific (GC/MS) methods. Isotopes Environ Health Std 2002; 38: 79-86.

  21. Rodríguez-Leal GA. Pruebas de función pancreática. En: Méndez N, Guevara L, Uribe M (eds.). Pruebas de laboratorio e imagen en gastroenterología y hepatología. 1a. Ed. México: Manual Moderno; 2001, p. 48-53.

  22. Dominguez-Muñoz J, Iglesias-Garcia J, Iglesias-Rey M, Figueiras A, Vilariño-Insua M. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three way crossover study. Aliment Pharmacol Ther 2005; 21: 993-1000.

  23. Stein J, Purschian B, Bieniek U, et al. Near-infrared reflectance analysis (NIRA): a new dimension in the investigation for malabsoption syndromes. Eur J Gastroenterol Hepatol 1994; 6: 889-94.




2020     |     www.medigraphic.com